Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial.
Jung HS, Choi J, Park SJ, Han Y, Cho YJ, Yoon J, Oh DY, Yoon YS, Kim JW, Lim CS, Park JH, Choi IS, Hong TH, Kim HS, Jeung HC, Ahn KS, Kim JY, Yu YD, Kim JW, Hwang HK, Lee CK, Choi HJ, Jung YK, Park K, Yoon JH, Han IW, Hong JY, Seo HI, Do Yang J, Jeon SY, Yang SJ, Chon HJ, Kwon W, Park JS, Shan YS, Lee MA, Jang JY.
Jung HS, et al. Among authors: han iw.
BMC Cancer. 2026 Feb 24. doi: 10.1186/s12885-026-15639-6. Online ahead of print.
BMC Cancer. 2026.
PMID: 41735896
Free article.
No abstract available.